Article
CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression.
PloS one - 1 Jan 2017
Liu Yingjie, Wei Jinhong, Wong King Yuen Siobhan M, Sun Bo, Tang Yijun, Wang Ruiwu, Van Petegem Filip, Chen S R Wayne
Abstract excerpt
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is one of the most lethal inherited cardiac arrhythmias mostly linked to cardiac ryanodine receptor (RyR2) mutations with high disease penetrance. Interestingly, a novel RyR2 mutation G357S discovered in a large family of more than 1400 individuals has reduced penetrance. The molecular basis for the incomplete disease penetrance in this family is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
